| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Software | 13 | 2023 | 736 | 3.580 |
Why?
|
| Computational Biology | 15 | 2025 | 890 | 3.560 |
Why?
|
| Transcriptome | 17 | 2025 | 1135 | 2.840 |
Why?
|
| Sequence Analysis, RNA | 12 | 2024 | 424 | 2.430 |
Why?
|
| Gene Expression Profiling | 20 | 2023 | 1922 | 2.410 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 15 | 2024 | 312 | 2.030 |
Why?
|
| Gene Regulatory Networks | 9 | 2023 | 400 | 1.720 |
Why?
|
| Polyadenylation | 4 | 2024 | 56 | 1.700 |
Why?
|
| Algorithms | 9 | 2024 | 1739 | 1.280 |
Why?
|
| Alzheimer Disease | 11 | 2025 | 883 | 1.260 |
Why?
|
| Single-Cell Analysis | 4 | 2025 | 356 | 1.250 |
Why?
|
| Models, Statistical | 3 | 2023 | 507 | 1.230 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2018 | 965 | 1.170 |
Why?
|
| Rett Syndrome | 9 | 2024 | 294 | 1.090 |
Why?
|
| Statistics as Topic | 2 | 2017 | 261 | 1.010 |
Why?
|
| Neural Stem Cells | 3 | 2025 | 152 | 0.920 |
Why?
|
| Markov Chains | 2 | 2016 | 99 | 0.900 |
Why?
|
| Databases, Genetic | 6 | 2019 | 507 | 0.900 |
Why?
|
| tau Proteins | 7 | 2023 | 241 | 0.880 |
Why?
|
| PubMed | 1 | 2023 | 23 | 0.840 |
Why?
|
| Disease Susceptibility | 3 | 2022 | 320 | 0.760 |
Why?
|
| Gene Expression Regulation | 8 | 2024 | 2669 | 0.760 |
Why?
|
| Disease Models, Animal | 21 | 2025 | 4802 | 0.750 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2015 | 1070 | 0.740 |
Why?
|
| Poly A | 1 | 2021 | 60 | 0.720 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2019 | 73 | 0.710 |
Why?
|
| Nervous System Diseases | 3 | 2024 | 411 | 0.680 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2022 | 548 | 0.680 |
Why?
|
| Animals | 62 | 2025 | 36526 | 0.660 |
Why?
|
| Herpesvirus 7, Human | 1 | 2019 | 3 | 0.660 |
Why?
|
| Mice | 44 | 2025 | 19049 | 0.650 |
Why?
|
| Roseolovirus Infections | 1 | 2019 | 30 | 0.640 |
Why?
|
| Medicine | 2 | 2017 | 107 | 0.630 |
Why?
|
| Herpesvirus 6, Human | 1 | 2019 | 55 | 0.630 |
Why?
|
| Genomics | 5 | 2019 | 1678 | 0.600 |
Why?
|
| Hippocampus | 7 | 2025 | 864 | 0.600 |
Why?
|
| Brain | 14 | 2023 | 3226 | 0.590 |
Why?
|
| Neurons | 10 | 2024 | 2051 | 0.590 |
Why?
|
| Base Pairing | 1 | 2018 | 43 | 0.590 |
Why?
|
| Spinocerebellar Ataxias | 4 | 2022 | 254 | 0.560 |
Why?
|
| RNA | 3 | 2024 | 607 | 0.560 |
Why?
|
| MicroRNAs | 5 | 2020 | 949 | 0.550 |
Why?
|
| Nerve Tissue Proteins | 7 | 2019 | 1167 | 0.550 |
Why?
|
| RNA Splicing | 5 | 2019 | 254 | 0.550 |
Why?
|
| Biology | 1 | 2017 | 29 | 0.550 |
Why?
|
| CRISPR-Cas Systems | 2 | 2019 | 298 | 0.530 |
Why?
|
| Cell Differentiation | 5 | 2020 | 2044 | 0.520 |
Why?
|
| Internationality | 1 | 2017 | 138 | 0.520 |
Why?
|
| Ataxin-1 | 5 | 2022 | 162 | 0.510 |
Why?
|
| Sequence Analysis, DNA | 4 | 2019 | 1835 | 0.510 |
Why?
|
| Congresses as Topic | 1 | 2017 | 191 | 0.500 |
Why?
|
| Oligonucleotides, Antisense | 3 | 2024 | 88 | 0.500 |
Why?
|
| Humans | 73 | 2025 | 134225 | 0.480 |
Why?
|
| Linear Models | 1 | 2017 | 723 | 0.460 |
Why?
|
| Alternative Splicing | 1 | 2017 | 379 | 0.460 |
Why?
|
| Genome, Human | 4 | 2019 | 1350 | 0.440 |
Why?
|
| Drosophila melanogaster | 8 | 2023 | 845 | 0.440 |
Why?
|
| Programming, Linear | 1 | 2014 | 4 | 0.440 |
Why?
|
| Reproducibility of Results | 8 | 2024 | 3056 | 0.420 |
Why?
|
| Huntington Disease | 3 | 2021 | 146 | 0.420 |
Why?
|
| Transcription, Genetic | 5 | 2024 | 1762 | 0.410 |
Why?
|
| Breast Neoplasms | 5 | 2021 | 2771 | 0.390 |
Why?
|
| Ovarian Neoplasms | 2 | 2014 | 469 | 0.390 |
Why?
|
| RNA Interference | 4 | 2019 | 549 | 0.380 |
Why?
|
| Tauopathies | 3 | 2023 | 78 | 0.380 |
Why?
|
| Chromatin | 3 | 2024 | 617 | 0.360 |
Why?
|
| 3' Untranslated Regions | 3 | 2021 | 183 | 0.360 |
Why?
|
| DNA Copy Number Variations | 7 | 2024 | 1036 | 0.340 |
Why?
|
| Cerebellum | 5 | 2022 | 467 | 0.330 |
Why?
|
| Phenotype | 7 | 2024 | 4611 | 0.320 |
Why?
|
| ras Proteins | 2 | 2018 | 146 | 0.320 |
Why?
|
| GABAergic Neurons | 2 | 2020 | 64 | 0.300 |
Why?
|
| Repressor Proteins | 3 | 2019 | 874 | 0.300 |
Why?
|
| Autism Spectrum Disorder | 3 | 2020 | 429 | 0.300 |
Why?
|
| Synapses | 4 | 2022 | 470 | 0.300 |
Why?
|
| DNA Probes | 1 | 2008 | 126 | 0.300 |
Why?
|
| Signal Transduction | 7 | 2025 | 4939 | 0.300 |
Why?
|
| Oligonucleotides | 1 | 2008 | 94 | 0.290 |
Why?
|
| Neuronal Plasticity | 3 | 2020 | 288 | 0.290 |
Why?
|
| Tumor Microenvironment | 3 | 2022 | 700 | 0.290 |
Why?
|
| DNA-Binding Proteins | 5 | 2021 | 2178 | 0.290 |
Why?
|
| Drosophila Proteins | 5 | 2021 | 773 | 0.280 |
Why?
|
| Databases, Factual | 4 | 2023 | 1260 | 0.280 |
Why?
|
| DNA Primers | 1 | 2008 | 673 | 0.280 |
Why?
|
| Regression Analysis | 2 | 2008 | 827 | 0.280 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2008 | 142 | 0.280 |
Why?
|
| RNA Splicing Factors | 2 | 2018 | 55 | 0.280 |
Why?
|
| Computer Simulation | 3 | 2017 | 709 | 0.270 |
Why?
|
| Nerve Degeneration | 2 | 2019 | 131 | 0.270 |
Why?
|
| Memory Disorders | 2 | 2020 | 235 | 0.270 |
Why?
|
| DNA Transposable Elements | 2 | 2018 | 189 | 0.270 |
Why?
|
| Histones | 3 | 2024 | 572 | 0.260 |
Why?
|
| Biomarkers, Tumor | 2 | 2021 | 1721 | 0.260 |
Why?
|
| Mice, Transgenic | 9 | 2025 | 2538 | 0.250 |
Why?
|
| Biomarkers | 5 | 2025 | 3434 | 0.250 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 489 | 0.240 |
Why?
|
| Drosophila | 5 | 2023 | 829 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2025 | 218 | 0.240 |
Why?
|
| Female | 34 | 2024 | 72054 | 0.230 |
Why?
|
| Poisson Distribution | 2 | 2016 | 52 | 0.230 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2025 | 16 | 0.230 |
Why?
|
| Mutation | 10 | 2023 | 6350 | 0.230 |
Why?
|
| Gene Knockdown Techniques | 5 | 2018 | 400 | 0.230 |
Why?
|
| Genetic Variation | 4 | 2019 | 1630 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 11 | 2024 | 4883 | 0.220 |
Why?
|
| Intellectual Disability | 4 | 2020 | 1096 | 0.220 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2024 | 232 | 0.220 |
Why?
|
| Proteolysis | 1 | 2025 | 198 | 0.210 |
Why?
|
| Physical Conditioning, Animal | 1 | 2025 | 99 | 0.210 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2020 | 1051 | 0.210 |
Why?
|
| Small Molecule Libraries | 1 | 2025 | 138 | 0.210 |
Why?
|
| Cell Transdifferentiation | 1 | 2024 | 62 | 0.210 |
Why?
|
| Seizures | 2 | 2020 | 892 | 0.210 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2023 | 16 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 2137 | 0.200 |
Why?
|
| Behavior, Animal | 4 | 2021 | 522 | 0.200 |
Why?
|
| Histone Demethylases | 1 | 2023 | 43 | 0.200 |
Why?
|
| Neuroglia | 2 | 2023 | 215 | 0.200 |
Why?
|
| Spliceosomes | 2 | 2019 | 57 | 0.190 |
Why?
|
| Protein Stability | 2 | 2021 | 175 | 0.190 |
Why?
|
| Microfilament Proteins | 3 | 2019 | 289 | 0.190 |
Why?
|
| Models, Biological | 6 | 2022 | 1538 | 0.190 |
Why?
|
| Base Sequence | 5 | 2018 | 3181 | 0.190 |
Why?
|
| Fibroblasts | 2 | 2024 | 918 | 0.180 |
Why?
|
| Haploinsufficiency | 2 | 2020 | 274 | 0.180 |
Why?
|
| Electrical Synapses | 1 | 2021 | 13 | 0.180 |
Why?
|
| Transcription Factors | 2 | 2022 | 2735 | 0.180 |
Why?
|
| Pleural Neoplasms | 3 | 2009 | 81 | 0.180 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2021 | 38 | 0.180 |
Why?
|
| Huntingtin Protein | 1 | 2021 | 65 | 0.170 |
Why?
|
| Mesothelioma | 3 | 2009 | 93 | 0.170 |
Why?
|
| Neurogenesis | 2 | 2025 | 223 | 0.170 |
Why?
|
| Mice, Knockout | 8 | 2024 | 4012 | 0.170 |
Why?
|
| Multiprotein Complexes | 1 | 2022 | 219 | 0.170 |
Why?
|
| Gene Ontology | 1 | 2020 | 55 | 0.170 |
Why?
|
| Cell Line, Tumor | 7 | 2025 | 3800 | 0.170 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2020 | 15 | 0.170 |
Why?
|
| 5' Untranslated Regions | 1 | 2020 | 61 | 0.170 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2020 | 17 | 0.170 |
Why?
|
| Brain Stem | 1 | 2021 | 119 | 0.170 |
Why?
|
| Transcription Factors, General | 1 | 2020 | 7 | 0.170 |
Why?
|
| Neoplasms, Adipose Tissue | 1 | 2020 | 8 | 0.160 |
Why?
|
| COUP Transcription Factor I | 1 | 2020 | 91 | 0.160 |
Why?
|
| Interferon-beta | 1 | 2020 | 54 | 0.160 |
Why?
|
| RNA, Messenger | 4 | 2021 | 2915 | 0.160 |
Why?
|
| Male | 26 | 2024 | 66215 | 0.160 |
Why?
|
| Abdominal Neoplasms | 1 | 2020 | 32 | 0.160 |
Why?
|
| Amyloid | 1 | 2020 | 69 | 0.160 |
Why?
|
| Neoplasm Metastasis | 2 | 2021 | 745 | 0.160 |
Why?
|
| Genome | 3 | 2018 | 529 | 0.160 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2019 | 33 | 0.160 |
Why?
|
| Cells, Cultured | 7 | 2021 | 3181 | 0.160 |
Why?
|
| Bone Neoplasms | 2 | 2021 | 447 | 0.160 |
Why?
|
| Reference Standards | 1 | 2020 | 247 | 0.160 |
Why?
|
| Adaptation, Physiological | 1 | 2021 | 289 | 0.150 |
Why?
|
| Metabolomics | 2 | 2023 | 471 | 0.150 |
Why?
|
| Chromosome Disorders | 2 | 2019 | 316 | 0.150 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2019 | 17 | 0.150 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2019 | 38 | 0.150 |
Why?
|
| Syndrome | 2 | 2020 | 1176 | 0.150 |
Why?
|
| Complement C3a | 1 | 2018 | 19 | 0.150 |
Why?
|
| Interneurons | 1 | 2020 | 147 | 0.150 |
Why?
|
| RNA, Nuclear | 1 | 2018 | 4 | 0.150 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 277 | 0.150 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2019 | 55 | 0.150 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 365 | 0.150 |
Why?
|
| Bone and Bones | 1 | 2021 | 311 | 0.150 |
Why?
|
| Receptors, Complement | 1 | 2018 | 33 | 0.150 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 869 | 0.150 |
Why?
|
| Topotecan | 1 | 2018 | 50 | 0.150 |
Why?
|
| Genes | 1 | 2019 | 450 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 115 | 0.150 |
Why?
|
| Polycomb-Group Proteins | 1 | 2018 | 22 | 0.150 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2020 | 160 | 0.150 |
Why?
|
| Gene Targeting | 1 | 2019 | 185 | 0.140 |
Why?
|
| Hypoglycemia | 1 | 2020 | 193 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 5 | 2018 | 1626 | 0.140 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2018 | 13 | 0.140 |
Why?
|
| Species Specificity | 3 | 2020 | 570 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 262 | 0.140 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 160 | 0.140 |
Why?
|
| Bias | 1 | 2018 | 147 | 0.140 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2018 | 192 | 0.140 |
Why?
|
| Inventions | 1 | 2017 | 20 | 0.140 |
Why?
|
| Meningioma | 1 | 2019 | 141 | 0.140 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 110 | 0.140 |
Why?
|
| Cell Line | 6 | 2021 | 2866 | 0.140 |
Why?
|
| Endopeptidases | 1 | 2018 | 119 | 0.140 |
Why?
|
| Alleles | 4 | 2024 | 1724 | 0.140 |
Why?
|
| alpha-Synuclein | 1 | 2018 | 134 | 0.140 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 830 | 0.140 |
Why?
|
| Hypothalamus | 1 | 2019 | 223 | 0.130 |
Why?
|
| Meningeal Neoplasms | 1 | 2019 | 217 | 0.130 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 116 | 0.130 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 623 | 0.130 |
Why?
|
| Longevity | 1 | 2018 | 159 | 0.130 |
Why?
|
| Computer Graphics | 1 | 2016 | 40 | 0.130 |
Why?
|
| Hearing | 1 | 2016 | 62 | 0.130 |
Why?
|
| Gene Editing | 1 | 2019 | 213 | 0.130 |
Why?
|
| Leiomyoma | 1 | 2017 | 85 | 0.130 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 92 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 189 | 0.130 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 163 | 0.130 |
Why?
|
| Hair Cells, Auditory | 1 | 2016 | 65 | 0.130 |
Why?
|
| Cochlea | 1 | 2016 | 90 | 0.130 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 112 | 0.130 |
Why?
|
| Genes, Duplicate | 1 | 2015 | 16 | 0.120 |
Why?
|
| HEK293 Cells | 4 | 2021 | 825 | 0.120 |
Why?
|
| Protein Isoforms | 1 | 2017 | 433 | 0.120 |
Why?
|
| Frontotemporal Dementia | 1 | 2016 | 74 | 0.120 |
Why?
|
| Memory | 1 | 2019 | 358 | 0.120 |
Why?
|
| Cognition Disorders | 2 | 2018 | 579 | 0.120 |
Why?
|
| Astrocytes | 1 | 2018 | 273 | 0.120 |
Why?
|
| Epilepsy | 2 | 2020 | 898 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2025 | 1854 | 0.120 |
Why?
|
| Receptors, Notch | 1 | 2016 | 214 | 0.110 |
Why?
|
| Progesterone | 1 | 2017 | 636 | 0.110 |
Why?
|
| Nuclear Proteins | 2 | 2022 | 1351 | 0.110 |
Why?
|
| Nuclear Matrix | 2 | 2005 | 21 | 0.110 |
Why?
|
| Software Design | 1 | 2014 | 24 | 0.110 |
Why?
|
| Inheritance Patterns | 1 | 2014 | 131 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 628 | 0.110 |
Why?
|
| Mutation, Missense | 1 | 2019 | 948 | 0.110 |
Why?
|
| Gene Dosage | 1 | 2015 | 458 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 285 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 2171 | 0.110 |
Why?
|
| Machine Learning | 1 | 2017 | 344 | 0.110 |
Why?
|
| YY1 Transcription Factor | 1 | 2013 | 18 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 625 | 0.100 |
Why?
|
| Serine | 1 | 2014 | 185 | 0.100 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 468 | 0.100 |
Why?
|
| Disease | 1 | 2014 | 133 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 390 | 0.100 |
Why?
|
| Drug Combinations | 1 | 2014 | 284 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 1317 | 0.100 |
Why?
|
| Deep Brain Stimulation | 1 | 2018 | 427 | 0.100 |
Why?
|
| Hypoxia | 1 | 2014 | 268 | 0.100 |
Why?
|
| COUP Transcription Factor II | 1 | 2013 | 117 | 0.100 |
Why?
|
| Cytokines | 1 | 2018 | 1397 | 0.100 |
Why?
|
| Trophoblasts | 1 | 2013 | 122 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 645 | 0.090 |
Why?
|
| Models, Genetic | 2 | 2013 | 790 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 3509 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 1626 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 3869 | 0.090 |
Why?
|
| Cerebellar Neoplasms | 1 | 2015 | 461 | 0.090 |
Why?
|
| Depression | 1 | 2020 | 1365 | 0.090 |
Why?
|
| Gene Expression | 4 | 2020 | 1622 | 0.090 |
Why?
|
| DNA Methylation | 2 | 2018 | 1148 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1621 | 0.090 |
Why?
|
| Aging | 3 | 2023 | 1308 | 0.080 |
Why?
|
| Medulloblastoma | 1 | 2015 | 571 | 0.080 |
Why?
|
| Disease Progression | 4 | 2021 | 2265 | 0.080 |
Why?
|
| Ovary | 1 | 2013 | 390 | 0.080 |
Why?
|
| Asbestos | 2 | 2009 | 13 | 0.080 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 1486 | 0.080 |
Why?
|
| Cell Proliferation | 4 | 2021 | 2564 | 0.080 |
Why?
|
| Protein Binding | 3 | 2022 | 1861 | 0.080 |
Why?
|
| Cluster Analysis | 2 | 2023 | 440 | 0.080 |
Why?
|
| Myxococcales | 1 | 2008 | 1 | 0.080 |
Why?
|
| Gene Duplication | 2 | 2024 | 372 | 0.080 |
Why?
|
| Mitochondria | 1 | 2014 | 759 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1774 | 0.080 |
Why?
|
| Base Composition | 1 | 2008 | 75 | 0.080 |
Why?
|
| Logistic Models | 1 | 2013 | 1909 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 719 | 0.070 |
Why?
|
| Immunohistochemistry | 4 | 2017 | 1764 | 0.070 |
Why?
|
| Purkinje Cells | 2 | 2022 | 166 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 3978 | 0.070 |
Why?
|
| Open Reading Frames | 1 | 2008 | 220 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2015 | 890 | 0.070 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2009 | 246 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2009 | 345 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2014 | 1105 | 0.070 |
Why?
|
| Genome, Bacterial | 1 | 2008 | 212 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 510 | 0.060 |
Why?
|
| Dendritic Spines | 2 | 2018 | 61 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2020 | 914 | 0.060 |
Why?
|
| Asbestosis | 1 | 2005 | 2 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 1098 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2021 | 1715 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 48 | 0.060 |
Why?
|
| Proteins | 2 | 2023 | 1100 | 0.060 |
Why?
|
| Mammary Glands, Animal | 1 | 2008 | 479 | 0.060 |
Why?
|
| Heterografts | 2 | 2015 | 201 | 0.060 |
Why?
|
| Acetylation | 1 | 2024 | 196 | 0.050 |
Why?
|
| Occupational Exposure | 1 | 2005 | 139 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2025 | 186 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2025 | 134 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2017 | 1138 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2024 | 143 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2021 | 718 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2025 | 278 | 0.050 |
Why?
|
| Locus Control Region | 1 | 2003 | 8 | 0.050 |
Why?
|
| Globins | 1 | 2003 | 36 | 0.050 |
Why?
|
| Neoplasms | 2 | 2015 | 3036 | 0.050 |
Why?
|
| Maternal Inheritance | 1 | 2023 | 15 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2025 | 303 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1419 | 0.050 |
Why?
|
| Growth Differentiation Factors | 1 | 2023 | 12 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2021 | 3678 | 0.050 |
Why?
|
| Regulatory Factor X1 | 1 | 2022 | 6 | 0.050 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2023 | 19 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2003 | 171 | 0.050 |
Why?
|
| Claudins | 1 | 2022 | 31 | 0.050 |
Why?
|
| K562 Cells | 2 | 2018 | 100 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 307 | 0.050 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2023 | 130 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2025 | 393 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 721 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 1434 | 0.050 |
Why?
|
| Electroencephalography | 2 | 2018 | 897 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2019 | 811 | 0.050 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2021 | 13 | 0.050 |
Why?
|
| Gap Junctions | 1 | 2021 | 45 | 0.040 |
Why?
|
| Clonal Evolution | 1 | 2021 | 49 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2021 | 69 | 0.040 |
Why?
|
| Locomotion | 1 | 2021 | 64 | 0.040 |
Why?
|
| Oocytes | 1 | 2023 | 302 | 0.040 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2021 | 83 | 0.040 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2021 | 85 | 0.040 |
Why?
|
| Rats | 2 | 2019 | 3876 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2021 | 233 | 0.040 |
Why?
|
| Apoptosis | 2 | 2021 | 1945 | 0.040 |
Why?
|
| Research Personnel | 1 | 2022 | 135 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 318 | 0.040 |
Why?
|
| Computers | 1 | 2020 | 71 | 0.040 |
Why?
|
| Cell Communication | 1 | 2021 | 192 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2022 | 426 | 0.040 |
Why?
|
| Complement C3 | 1 | 2020 | 54 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2021 | 399 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2021 | 168 | 0.040 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2019 | 17 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 403 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2022 | 209 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2021 | 615 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 780 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2022 | 520 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 1109 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 543 | 0.040 |
Why?
|
| Post-Synaptic Density | 1 | 2019 | 11 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2014 | 532 | 0.040 |
Why?
|
| Receptors, GABA-A | 1 | 2019 | 59 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2020 | 162 | 0.040 |
Why?
|
| Microglia | 1 | 2020 | 139 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2020 | 417 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 337 | 0.040 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2019 | 130 | 0.040 |
Why?
|
| Prosencephalon | 1 | 2018 | 43 | 0.040 |
Why?
|
| Fornix, Brain | 1 | 2018 | 20 | 0.040 |
Why?
|
| Evoked Potentials | 1 | 2018 | 124 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2018 | 100 | 0.040 |
Why?
|
| Argonaute Proteins | 1 | 2018 | 31 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 1013 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2018 | 122 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2018 | 250 | 0.030 |
Why?
|
| Macrophages | 1 | 2022 | 710 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2020 | 541 | 0.030 |
Why?
|
| Role | 1 | 2017 | 30 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2018 | 74 | 0.030 |
Why?
|
| Receptor, Notch1 | 1 | 2018 | 80 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 173 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 7244 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 284 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 337 | 0.030 |
Why?
|
| Gene Library | 1 | 2018 | 225 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2018 | 163 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 344 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2019 | 283 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2019 | 625 | 0.030 |
Why?
|
| Organ of Corti | 1 | 2016 | 26 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 237 | 0.030 |
Why?
|
| Rats, Transgenic | 1 | 2016 | 15 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2016 | 154 | 0.030 |
Why?
|
| Ear, Inner | 1 | 2016 | 50 | 0.030 |
Why?
|
| Databases, Bibliographic | 1 | 2016 | 20 | 0.030 |
Why?
|
| Internet | 1 | 2019 | 404 | 0.030 |
Why?
|
| Lysosomes | 1 | 2018 | 266 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2024 | 14897 | 0.030 |
Why?
|
| Motor Activity | 1 | 2019 | 531 | 0.030 |
Why?
|
| Attachment Sites, Microbiological | 1 | 2015 | 7 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 186 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2013 | 1595 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1732 | 0.030 |
Why?
|
| Homozygote | 1 | 2018 | 571 | 0.030 |
Why?
|
| Luciferases | 1 | 2015 | 139 | 0.030 |
Why?
|
| Lentivirus | 1 | 2015 | 86 | 0.030 |
Why?
|
| Prognosis | 2 | 2019 | 5085 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 94 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2018 | 691 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 206 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2017 | 635 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 229 | 0.030 |
Why?
|
| Autistic Disorder | 1 | 2019 | 376 | 0.030 |
Why?
|
| Adult | 3 | 2023 | 31962 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 547 | 0.030 |
Why?
|
| Registries | 1 | 2022 | 1588 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1041 | 0.030 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 2014 | 6 | 0.030 |
Why?
|
| Action Potentials | 1 | 2018 | 523 | 0.030 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2014 | 6 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2017 | 398 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 666 | 0.030 |
Why?
|
| Integrases | 1 | 2015 | 163 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 297 | 0.030 |
Why?
|
| Genes, myc | 1 | 2014 | 107 | 0.030 |
Why?
|
| Regeneration | 1 | 2016 | 230 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 1333 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 105 | 0.030 |
Why?
|
| Exons | 1 | 2016 | 839 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2014 | 247 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 259 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 2822 | 0.030 |
Why?
|
| X Chromosome | 1 | 2014 | 342 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1308 | 0.030 |
Why?
|
| Aged | 3 | 2019 | 21822 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 771 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 178 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2018 | 473 | 0.020 |
Why?
|
| CpG Islands | 1 | 2013 | 347 | 0.020 |
Why?
|
| Genomic Imprinting | 1 | 2013 | 130 | 0.020 |
Why?
|
| Inflammation | 1 | 2020 | 1595 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 890 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2013 | 371 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2013 | 314 | 0.020 |
Why?
|
| Middle Aged | 3 | 2019 | 29430 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 2319 | 0.020 |
Why?
|
| Homeostasis | 1 | 2014 | 751 | 0.020 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 1386 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2009 | 54 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1436 | 0.020 |
Why?
|
| Fetus | 1 | 2013 | 601 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 1493 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 673 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2013 | 937 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 787 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 677 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 972 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 11196 | 0.020 |
Why?
|
| Cell Movement | 1 | 2009 | 920 | 0.010 |
Why?
|
| Osteopontin | 1 | 2005 | 53 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2793 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 9963 | 0.010 |
Why?
|
| RNA, Complementary | 1 | 2004 | 5 | 0.010 |
Why?
|
| Child | 1 | 2024 | 25917 | 0.010 |
Why?
|
| ROC Curve | 1 | 2005 | 614 | 0.010 |
Why?
|
| Time Factors | 2 | 2004 | 6595 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2005 | 840 | 0.010 |
Why?
|
| Actins | 1 | 2005 | 353 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 1391 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 1470 | 0.010 |
Why?
|